HDL phospholipid: A natural inhibitor of Alzheimer's amyloid β-fibrillogenesis? [2]

[No abstract available]

Авторы
Koudinov A.R.1, 2, 3, 4, 6 , Koudinova N.V.1, 2, 4 , Berezov T.T. 1, 2, 5 , Ivanov Y.D.1
Редакторы
-
Издательство
-
Номер выпуска
10
Язык
Английский
Страницы
993-994
Статус
Опубликовано
Подразделение
-
DOI
-
Номер
-
Том
37
Год
1999
Организации
  • 1 Institute of Biomedical Chemistry, Moscow, Russian Federation
  • 2 Russian Academy of Medical Sciences, Moscow, Russian Federation
  • 3 Natl. Mental Health Research Center, Moscow, Russian Federation
  • 4 Weizmann Institute, Department of Neurobiology, Rehovot, Israel
  • 5 Department of Biochemistry, Russ. People's Friendship Univ. S., Moscow, Russian Federation
  • 6 Department of Neurobiology, Brain Research Jaglom Bldg., Weizmann Institute of Science, Rehovot 76100, Israel
Ключевые слова
amyloid beta protein; apolipoprotein; dimyristoylphosphatidylcholine; high density lipoprotein; phosphatidylcholine; phospholipid; Alzheimer disease; competitive inhibition; human; letter; priority journal; protein binding; protein cerebrospinal fluid level; protein secondary structure; proteoliposome; Raman spectrometry; solution and solubility; Alzheimer Disease; Amyloid beta-Protein; Circular Dichroism; Dimyristoylphosphatidylcholine; Humans; Lipoproteins, HDL; Neurofibrils; Protein Structure, Secondary; Spectrum Analysis, Raman
Дата создания
19.10.2018
Дата изменения
19.10.2018
Постоянная ссылка
https://repository.rudn.ru/ru/records/article/record/526/